Toceranib

14 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

4290.0%

Death Rate

Active Ingredients

Toceranib

Administration Routes

OralUnknown

Species Affected

Dog 11

Unknown 3

Most Affected Breeds

Boxer (German Boxer) 3

Unknown 3

Retriever - Golden 1

Terrier - Jack Russell 1

Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1

Pug 1

Chihuahua 1

Shih Tzu 1

Terrier - Bull - American Pit 1

Beagle 1

Most Reported Reactions

Death by euthanasia 5

Constipation 3

Anorexia 3

Localised pain NOS (see other 'SOCs' for specific pain) 3

Hind limb ataxia 3

Lethargy (see also Central nervous system depression in 'Neurological') 3

Diarrhoea 3

Vomiting 2

Appetite loss 2

Elevated alanine aminotransferase (ALT) 2

Elevated serum alkaline phosphatase (SAP) 2

Decreased appetite 2

Outcome Breakdown

Euthanized

5 (45.5%)

Ongoing

3 (27.3%)

Outcome Unknown

1 (9.1%)

Recovered with Sequela

1 (9.1%)

Died

1 (9.1%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.